HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,930.00
-50.00 (-1.26%)
At close: May 29, 2026
Market Cap112.95B -12.7%
Revenue (ttm)135.04B +8.5%
Net Income12.48B
EPS416.13
Shares Out 30.00M
PE Ratio9.05
Forward PEn/a
Dividend35.00 (0.89%)
Ex-Dividend DateApr 2, 2026
Volume83,787
Open3,995.00
Previous Close3,980.00
Day's Range3,860.00 - 3,995.00
52-Week Range3,845.00 - 5,420.00
Beta0.85
Analystsn/a
Price Targetn/a
Earnings DateJul 31, 2026

About HYUNDAI BIOLAND

HYUNDAI BIOLAND Co.,Ltd., together with its subsidiaries, manufactures and sells cosmetic raw materials, health food raw materials, medical devices, and pharmaceutical raw materials worldwide. The company offers cosmetics, such as whitening, skin protection, moisturizing, anti-aging, sheet mask, and hair and body care products, as well as general/health functional food ingredients. It is also involved in the provision of medical biomaterials for dental, wound, orthopedic, and biomaterial applications; and manufacture and supplying of active pha... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 341
Stock Exchange KOSDAQ
Ticker Symbol 052260
Full Company Profile

Financial Performance

In 2025, HYUNDAI BIOLAND's revenue was 130.51 billion, an increase of 9.19% compared to the previous year's 119.52 billion. Earnings were 252.62 million, a decrease of -95.57%.

Financial Statements